In Q4 2009 Redbiotec demonstrated a specific immune response of its nature-like influenza virus-like particles in mice. The particles represent an ideal vaccine candidate as they contain all major virus antigens in one virus-like particle.
In Q4 2009 Redbiotec demonstrated a specific immune response of its nature-like influenza virus-like particles in mice. The particles represent an ideal vaccine candidate as they contain all major virus antigens in one virus-like particle.